FDA Inspection 791919 — Genzyme Corporation

Genzyme Corporation — FEI 1220423

The FDA completed an inspection of Genzyme Corporation on July 13, 2012 in Framingham, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 13, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Framingham, MA (United States)